A CRISPR/Cas9‐based method for targeted DNA methylation enables cancer initiation in B lymphocytes
Open Access
- 11 March 2021
- journal article
- research article
- Published by Wiley in Advanced Genetics
- Vol. 2 (1), e10040
- https://doi.org/10.1002/ggn2.10040
Abstract
Targeted DNA methylation is important for understanding transcriptional modulation and epigenetic diseases. Although CRISPR‐Cas9 has potential for this purpose, it has not yet been successfully used to efficiently introduce DNA methylation and induce epigenetic diseases. We herein developed a new system that enables the replacement of an unmethylated promoter with a methylated promoter through microhomology‐mediated end joining‐based knock‐in. We successfully introduced an approximately 100% DNA methylation ratio at the cancer‐associated gene SP3 in HEK293 cells. Moreover, engineered SP3 promoter hypermethylation led to transcriptional suppression in human B lymphocytes and induced B‐cell lymphoma. Our system provides a promising framework for targeted DNA methylation and cancer initiation through epimutations.Keywords
This publication has 52 references indexed in Scilit:
- In vivo genome editing using Staphylococcus aureus Cas9Nature, 2015
- Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complexNature, 2014
- CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineeringNature Biotechnology, 2013
- DNA targeting specificity of RNA-guided Cas9 nucleasesNature Biotechnology, 2013
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- RNA-guided genetic silencing systems in bacteria and archaeaNature, 2012
- The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNANature, 2010
- Short motif sequences determine the targets of the prokaryotic CRISPR defence systemMicrobiology, 2009